CAD 0.03
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 3.46 Million CAD | -62.79% |
2022 | 2.97 Million CAD | 5151.86% |
2021 | 56.71 Thousand CAD | -98.81% |
2020 | 4.76 Million CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 288.54 Thousand CAD | -37.98% |
2024 Q3 | 1.37 Million CAD | 420.87% |
2024 Q1 | 465.21 Thousand CAD | 263.82% |
2023 Q3 | 1.11 Million CAD | 122.13% |
2023 FY | 1.1 Million CAD | -62.79% |
2023 Q1 | 127.2 Thousand CAD | -76.92% |
2023 Q2 | 500.18 Thousand CAD | 293.22% |
2023 Q4 | -283.97 Thousand CAD | -125.56% |
2022 Q4 | 551.13 Thousand CAD | -38.44% |
2022 Q3 | 895.31 Thousand CAD | 5.12% |
2022 FY | 2.97 Million CAD | 5151.86% |
2022 Q2 | 851.72 Thousand CAD | 25.16% |
2022 Q1 | 680.52 Thousand CAD | 112.6% |
2021 Q4 | -5.4 Million CAD | -199.18% |
2021 FY | 56.71 Thousand CAD | -98.81% |
2021 Q3 | 5.44 Million CAD | 44254.73% |
2021 Q1 | -105.00 CAD | -100.01% |
2021 Q2 | 12.27 Thousand CAD | 11793.33% |
2020 Q3 | 3.04 Million CAD | 0.0% |
2020 FY | 4.76 Million CAD | 0.0% |
2020 Q4 | 1.72 Million CAD | -43.51% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aion Therapeutic Inc. | -285.33 Thousand CAD | 1314.768% |
Ayurcann Holdings Corp. | 8.46 Million CAD | 59.055% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -4015.355% |
The BC Bud Corporation | 59.5 Thousand CAD | -5725.182% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -831.145% |
CordovaCann Corp. | 3.26 Million CAD | -6.016% |
Captor Capital Corp. | 16.93 Million CAD | 79.536% |
City View Green Holdings Inc. | -290.73 Thousand CAD | 1292.193% |
1CM Inc. | 7.6 Million CAD | 54.445% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 1133.511% |
IM Cannabis Corp. | 9.84 Million CAD | 64.796% |
Lobe Sciences Ltd. | 772.82 Thousand CAD | -348.504% |
Maple Leaf Green World Inc. | -17.85 Thousand CAD | 19513.902% |
Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 1101.78% |
Nextleaf Solutions Ltd. | 1.24 Million CAD | -177.857% |
Ovation Science Inc. | -251.43 Thousand CAD | 1478.572% |
Pharmadrug Inc. | -26.21 Thousand CAD | 13321.536% |
Captiva Verde Wellness Corp. | 163.43 Thousand CAD | -2020.856% |
RAMM Pharma Corp. | -902.83 Thousand CAD | 483.919% |
RIV Capital Inc. | -958.27 Thousand CAD | 461.707% |
Revive Therapeutics Ltd. | -328.00 CAD | 1056855.488% |
Red White & Bloom Brands Inc. | 29.48 Million CAD | 88.244% |
SLANG Worldwide Inc. | 18.61 Million CAD | 81.384% |
1933 Industries Inc. | -602.75 Thousand CAD | 675.05% |
Red Light Holland Corp. | 2.02 Million CAD | -71.552% |
Top Strike Resources Corp. | 2.84 Million CAD | -21.75% |
Xebra Brands Ltd. | -367.96 Thousand CAD | 1041.983% |
Adastra Holdings Ltd. | 7.03 Million CAD | 50.697% |